0001209191-17-066620.txt : 20171220
0001209191-17-066620.hdr.sgml : 20171220
20171220160434
ACCESSION NUMBER: 0001209191-17-066620
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171219
FILED AS OF DATE: 20171220
DATE AS OF CHANGE: 20171220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KELLOGG PETER N
CENTRAL INDEX KEY: 0001226287
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 171266825
MAIL ADDRESS:
STREET 1: MERCK & CO., INC
STREET 2: ONE MERCK DRIVE., P.O. BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-19
0
0000816284
CELGENE CORP /DE/
CELG
0001226287
KELLOGG PETER N
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
1
0
0
See Remarks
Common Stock
2017-12-19
4
M
0
3410
0.00
A
44145
D
Common Stock
2017-12-19
4
F
0
1768
107.06
D
42377
D
Common Stock
348
I
401(k) Plan
Restricted Stock Unit
2017-12-19
4
M
0
3410
0.00
D
Common Stock
3410
0
D
All of the restricted stock units granted to the reporting person on December 19, 2014 vested and settled for shares of the Company's common stock.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units were issued pursuant to The Celgene Corporation 2017 Stock Incentive Plan.
Executive Vice President and Chief Financial Officer
Mark J. Alles, Attorney-in-Fact
2017-12-20